Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: ease....

RE: ease....

posted on Jul 03, 2006 08:33AM
As I understand it, the longer the J3 wait the higher the license fees become. In simple terms each deal raises the bar (and in theory the price) because there are fewer ``slots`` in that price range. Each signing is another stone in the scales against them. I have to wonder if any who purchase a license can request exclusivity in their field. That would give the J3 incentive to act soon rather than later. Not that TPL would do that (?) but it could be a bargaining tactic.

The real incentive is the use of the technology or the fear of not being able to use it!

Share
New Message
Please login to post a reply